Takeair SRL
Takeair reported total assets of €1.52m at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Aug 2025).
The score of Takeair shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +140 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Takeair's annual accounts
| 2025 | 2024 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | −414,075 € | ||||
| Equity | 225,618 € | ||||
| Cash | 34,388 € | ||||
| EBITDA | −347,909 € | ||||
| Total assets | €1.52m |
Filed annual accounts
- Year ended 30 Jun 2025filed on 12 Aug 2025
- Year ended 30 Jun 2024filed on 28 Jan 2025
- Year ended 30 Sep 2022filed on 08 Sep 2023
- Year ended 30 Sep 2021filed on 29 Apr 2022
- Year ended 30 Sep 2020filed on 23 Dec 2020
Takeair's financial analysis
- Solvency14.8%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Takeair
Takeair's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0658.744.222
- VAT number
- BE0658744222
- Peppol
- Registered · 0208:0658744222 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Jul 2016
- Registered office
- 9700 Oudenaarde
- Latest accounts
- 2025 · filed on 12 Aug 2025
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Takeair (SRL) has been based in Oudenaarde since 2016, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 414,075 € and equity of 225,618 €; its revenue is not published. Its solvency stands at 14.8%, below the median of its sector (56.0%).
Companies similar to Takeair
Companies in the same business, of comparable size and area, outside its group.
- Bpharma Retail sale of pharmaceutical products Gerpinnes · balance sheet €1.24m
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Groupe Tete Pharmaceutical Manufacture of basic pharmaceutical products Nivelles · balance sheet €1.15m
- Société D’Études, Commercialisation ET Réalisation Manufacture of basic pharmaceutical products Anderlecht · balance sheet €1.70m
- Equibor Manufacture of basic pharmaceutical products Manage · balance sheet €1.12m
- Feton International Wholesale of pharmaceutical and medical goods La Louvière · balance sheet €1.39m
- Pharmacie Smits Manufacture of pharmaceutical preparations Wavre · balance sheet €1.86m
- Pharma Chemicals France Manufacture of basic pharmaceutical products Braine-le-Château · balance sheet €1.08m
Frequently asked questions about Takeair
What is the revenue of Takeair?
Takeair files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Takeair?
In Belgium, the VAT number is the company number prefixed with BE: BE0658744222 for Takeair, if the company is VAT-registered. Its company number (CBE) is 0658.744.222.
Where is the registered office of Takeair?
According to the CBE register, the registered office of Takeair is in 9700 Oudenaarde.
What is the equity of Takeair?
At the close of the 2025 financial year, the equity of Takeair amounts to 225,618 €, a solvency of 14.8% of total assets.
Who manages Takeair?
The register lists 2 active mandates at Takeair. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Takeair
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →